GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genedrive PLC (LSE:GDR) » Definitions » COGS-to-Revenue

Genedrive (LSE:GDR) COGS-to-Revenue : 0.00 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Genedrive COGS-to-Revenue?

Genedrive's Cost of Goods Sold for the six months ended in Dec. 2023 was £0.00 Mil. Its Revenue for the six months ended in Dec. 2023 was £0.24 Mil.

Genedrive's COGS to Revenue for the six months ended in Dec. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Genedrive's Gross Margin % for the six months ended in Dec. 2023 was N/A%.


Genedrive COGS-to-Revenue Historical Data

The historical data trend for Genedrive's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genedrive COGS-to-Revenue Chart

Genedrive Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Genedrive Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Genedrive COGS-to-Revenue Calculation

Genedrive's COGS to Revenue for the fiscal year that ended in Jun. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0.055
=0.00

Genedrive's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0.238
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genedrive  (LSE:GDR) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Genedrive's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0 / 0.238
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Genedrive COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Genedrive's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Genedrive (LSE:GDR) Business Description

Traded in Other Exchanges
Address
48 Grafton Street, The Incubator Building, Manchester, GBR, M13 9XX
Genedrive PLC is a holding company engaged in the molecular diagnostics business. It operates in one operating segment named Diagnostics which is engaged in the Genedrive Point of need molecular diagnostics platform for the diagnosis of infectious diseases and use in patient stratification (genotyping), pathogen detection, and other indications. Geographically the majority of the revenue is derived from the United Kingdom.

Genedrive (LSE:GDR) Headlines

No Headlines